Kaleido BiosciencesKLDO
13F holders, Q1 2026 (March 31)3holders +1
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2026, 3 institutions reported holding Kaleido Biosciences Inc. (KLDO) in their 13F filings, up 1 from Q4 2025. 1 opened new positions and 0 sold out. The largest holders were Hantz Financial Services, Inc. ($0), Bay Harbor Wealth Management, LLC ($0) and RMG Wealth Management LLC ($0).
- Company
- Kaleido Biosciences Inc.
- CUSIP
- 483347100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 70 shares bought, net +70 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Hantz Financial Services, Inc. | 0.00% | No change | 350 | $0 |
| Bay Harbor Wealth Management, LLC | 0.00% | No change | 2,300 | $0 |
| RMG Wealth Management LLC | 0.00% | New | 70 | $0 |
"% of holder's portfolio" is KLDO's weight in each manager's 13F, not the share of Kaleido Biosciences Inc. the manager owns.